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YXOPAPILLARY ependymoma, a histological sub-
type of ependymoma, most commonly appears in
the fourth decade of life; only 8 to 20% of these
tumors occur in the pediatric population.2,11,12 The vast ma-
jority of these lesions appear in the lumbar thecal sac in
association with the conus medullaris, cauda equina, or fi-
lum terminal.1,12 Less than 5% of MPEs occur as primary
tumors in sites outside the lumbar thecal sac; however, pri-
mary tumors of the cervical cord, brain, and osseous sac-
rum have been reported.6,12
On MR images, these tumors typically appear as a ho-
mogeneously enhancing sausage-shaped mass in the lum-
bar thecal sac (Fig. 1), with hyperintensity on T1-weighted
images resulting from the intracellular and perivascular ac-
cumulation of mucin.3
Historically, MPEs have been considered benign tumors
characterized by slow growth and a low likelihood for tu-
mor dissemination.11,13 They are known to recur locally, but
prior to the MR imaging era metastases were considered
rare. Only six cases of metastases were reported in the liter-
ature before 1996.14 Most reported cases of metastases have
occurred within the CNS, but extraneural metastases have
also been reported.10
During an 11-year period from 1992 to 2003, five cases
of intradural MPE were treated at our institution. In four of
the five patients metastatic disease was already apparent at
the time of presentation. The patients included four boys
and one girl who ranged in age from 7 to 14 years. All
patients presented with back pain and four with radicular
pain in the lower extremities. Resection was performed in
each patient and histologically confirmed MPE was diag-
nosed in every case. All of the patients in our series under-
went perioperative MR imaging, which included the entire
cranial spinal axis in four patients and images of the entire
spine in one. We have combined our series of patients with
pediatric series in the literature that included three or more
patients to investigate the incidence of tumor spread in pe-
diatric patients with MPE.
Case Reports
Case 1
This 13-year-old girl presented with a 7-month history of
progressive low-back and leg pain. She reported no numb-
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ness or weakness and had been treated with analgesic
agents, which provided no relief. An MR image demon-
strated a homogeneously enhancing sausage-shaped mass
extending from T-11 to L-2 and enhancing sediment at the
bottom of the thecal sac (Fig. 1). Preoperatively, MR
images had been obtained in only the thoracic and lumbar
spine. With the exception of an upgoing right toe the patient
was neurologically intact. Resection of the primary tumor,
including a T10–L2 laminoplasty and en bloc removal of
the tumor for gross-total resection, was performed. The
drop metastases in the distal thecal sac were not addressed
surgically. Histopathological findings confirmed the diag-
nosis of MPE. Postoperative neurological examination re-
vealed no change in her condition. On postoperative Day 1,
an MR image of the entire CNS axis demonstrated gross-
total tumor resection of the primary tumor mass, no evi-
dence of cervical or intracranial disease, and residual drop
metastases in the distal thecal sac. The patient was treated
with radiation therapy (4450 cGy) in the lower thoracic and
lumbosacral spine, including an extra dose targeted at the
sacral drop metastases; the total dosage was 5250 cGy. Fol-
low-up MR imaging at 3 months after radiation therapy re-
vealed no evidence of residual disease. The results of MR
surveillance imaging remained nondiagnostic for 30
months, but 3 years after the initial surgery the patient be-
gan to experience headaches and MR imaging demonstrat-
ed enhancing lesions in the supracellar cistern and fourth
ventricles (Fig. 2), with no evidence of spinal disease. Cra-
niospinal radiation therapy (3960 cGy) was administered
with an extra dose to the intracranial lesions (5420 cGy to
each lesion by using stereotactic intensity–modulated radi-
ation therapy). The intracranial lesions appeared slightly
smaller at the 15-month follow-up examination.
Case 2
This 14-year-old boy presented with 1 year of progres-
sive low-back pain that included no radiating pain, numb-
ness, weakness, or sphincter dysfunction. An MR imaging
examination revealed an enhancing mass from T-11 to L-3
as well as metastases in the cervicothoracic spinal cord and
brainstem. Results of the patient’s neurological examina-
tion were normal. A gross-total resection (T11–L3) of the
primary lesion was performed, and histopathological find-
ings confirmed the diagnosis of MPE. Postoperatively the
patient remained neurologically intact. The disseminated
disease was subsequently treated with craniospinal radia-
tion therapy (5086 cGy), and at the 5-year follow-up ex-
amination no residual disease was demonstrated on MR
imaging.
Case 3
This 14-year-old boy presented with a 6-year history of
progressive back pain, including nocturnal back pain, and
a 1-year history of pain radiating into both legs. He report-
ed no motor, sensory, bowel, or bladder dysfunction. An
MR imaging examination of the entire CNS revealed a 4-
cm enhancing mass just below the conus medullaris and
metastases on the thoracic cord, conus medullaris, and
caudal thecal sac. The patient’s neurological examination
was normal with the exception of symmetric hyperreflex-
ia in the lower extremities. He was treated with staged sur-
gical procedures. The first was a laminectomy from L-2 to
S-2, with subtotal resection of the large mass in the conus
medullaris, which was performed in a piecemeal fashion.
Small amounts of tumor that were adherent to multiple
nerve roots were left intact. Two weeks after his initial
surgery the patient underwent a second procedure to resect
focal metastases at the level of T-5 to T-6. Histopatho-
logical studies from both surgeries confirmed the diagno-
sis of MPE. The boy was then treated with radiation ther-
apy (4600 cGy) to the entire thoracic, lumbar, and sacral
spine. At the last follow-up examination, conducted 3.5
years posttreatment, no residual disease was apparent.
Case 4
This 7-year-old boy presented with progressive back
pain that worsened rapidly during a 2-week period. The
pain became so severe that he was unable to walk, sit, or
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FIG. 1. Case 1. Preoperative MR image demonstrating a homo-
geneously enhancing primary tumor at the level of the conus
medullaris (T11–L2) at the time of the initial presentation. 
stand without discomfort. No bowel or bladder symptoms
were reported. An MR image revealed an enhancing 3 ✸
2 ✸ 2–cm intradural hemorrhagic mass just below the co-
nus. An MR imaging examination of other areas of the
CNS was not performed preoperatively. Physical examina-
tion revealed mild proximal weakness in both legs and de-
creased sensation to pinprick below L-2. The patient under-
went T12–L2 laminoplasty and en bloc resection of the
mass. Histopathological findings confirmed the diagnosis
of MPE. After surgery the boy’s strength and sensation 
gradually returned to normal. An MR imaging examination
of his entire spine 1 month after surgery demonstrated no
evidence of disease. The patient did not undergo adjuvant
therapy, and he was healthy and active with no apparent
disease at the last follow-up examination conducted 7 years
postoperatively. 
Case 5
This 8-year-old boy presented with a 2-month history of
progressive low-back pain that radiated into his thighs. The
pain increased significantly when he bent forward. During
the 10 days prior to his admission the boy had difficulty
walking, which resulted from pain, and he experienced uri-
nary urgency with occasional episodes of incontinence. An
MR imaging examination demonstrated an enhancing in-
tradural mass distal to the conus from L-2 to L-3 and an en-
hancement of the distal conus distinct from the main mass,
which was believed to be a sign of drop metastases. Physi-
cal examination revealed normal motor function, dyses-
thetic pain in the thighs as a response to light touch, and an
absence of reflexes at the ankle and knee bilaterally. A sub-
total resection was performed because of the dense adher-
ence of tumor to nerve roots. Histopathological studies
confirmed the diagnosis of MPE. Postoperatively, the pa-
tient suffered no new neurological deficits, and urinary
function and sensation returned to normal. Lower-extremi-
ty reflexes returned with the exception of the left Achilles
reflex. The boy underwent radiation therapy (4500 cGy)
from T-11 to S-5, including an additional dose from L-1 to
L-3, resulting in a total dosage of 5400 cGy. He remains
neurologically stable 4.5 years after treatment. There is a
small area of enhancement at the tip of the conus that has
demonstrated no changes on MR imaging examinations. 
Combined Results From the Pediatric MPE Series
The five patients from our series were combined with
21 patients from five series from the literature to yield a
total of 26 patients (Table 1).1,2,5,8,11 Patient age ranged
from 5 to 17 years (mean 11.1 years). Seventeen boys and
nine girls are included, resulting in a male/female ratio of
1.89:1, a ratio similar to the mean ratio in adult series in
the literature.10 Twenty-two of the patients suffered from
primary disease in the lumbar thecal sac, one from prima-
ry tumor in the cervical cord,5 and three from primary tu-
mors the locations of which were not reported. 
Nine of the 26 patients experienced CNS tumor dissem-
ination at some point in the history of their disease. Seven
cases of CNS metastases occurred at the time of presenta-
tion and two during the follow-up period. Note that only 12
of the 26 patients were reported to have undergone periop-
erative screening for metastasis by using either MR imag-
ing or CSF cytology. The authors of the three case series
published before 1994, comprising 14 patients, did not re-
port any screening measures used to identify dissemination
in the perioperative period. In the three case series pub-
lished after 1994 screening measures for tumor dissemina-
tion were reported. The incidence of tumor dissemination
in the three series before 1994 (no screening for dissemina-
tion) was 14% and both of the cases in which dissemination
was present were found in the late follow-up period––more
than 3.5 years after surgery. The incidence of dissemination
in the three series that included perioperative screening was
58%, and all cases of dissemination were found at the
patient’s initial presentation. One patient in our series who
was at the time of presentation found to be suffering from
disseminated disease in her spine was treated with radiation
therapy and experienced an excellent response to therapy.
Subsequently late intracranial metastases developed; these
were treated with further radiation therapy. 
The initial treatment for all patients was resection of the
primary lesion. Whenever possible, the lesion was re-
moved en bloc to minimize the chance of dissemination.
Postsurgically, patients who underwent subtotal resection
were treated using local radiotherapy; patients suffering
from metastatic lesions were treated with involved-field
radiotherapy.
There were 14 patients without metastatic disease at
presentation who underwent gross-total resection of their
lesions. Eleven of these patients did not undergo adjuvant
radiotherapy. Two experienced local recurrence and two
others late disseminated disease. Of the three patients who
underwent gross-total resection and adjuvant radiation
therapy, none experienced recurrence. There were five
other patients without metastases at presentation who un-
derwent subtotal resection. Four of them who were treat-
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FIG. 2. Case 1. Magnetic resonance image demonstrating
enhancing lesions in the third and fourth ventricles found 3 years
postsurgery. 
ed with adjuvant radiotherapy did not experience a recur-
rence; however, a recurrence developed in the one who
was not treated with adjuvant radiotherapy.
Seven patients were suffering from known metastases at
presentation; two underwent gross-total resection of the
primary lesion and adjuvant radiotherapy to the metastatic
sites. One of these two patients later experienced cranial
metastases outside the radiotherapy field. The five patients
with known metastases at presentation who underwent sub-
total resection of the primary lesion were treated with ra-
diotherapy, and two were also treated with chemotherapy.
Recurrent disease did not develop in any of these patients.
A total of 11 patients were treated with radiotherapy for
either subtotal resection or metastatic disease that was evi-
dent at presentation. Only the patient with a cranial metas-
tasis outside the field (spinal) of radiotherapy experienced
progressive disease. Twelve patients did not receive radio-
therapy at the time of the initial treatment; 11 of these pa-
tients underwent gross-total resection and one a subtotal re-
section. The patient who underwent subtotal resection
experienced a recurrence. Progressive disease developed in
four of the 11 patients who underwent gross-total resection:
two experienced localized recurrence and two suffered
from disseminated disease.
The follow-up period ranged from 2 months to 21 years
with a mean of 6.1 years. At the time of the last reported
follow-up examination, 23 patients demonstrated no appar-
ent residual disease, two had stable disease, and one patient
had died of other causes. No patient suffered uncontrolled
tumors or died as a result of a tumor. 
Discussion
Incidence of Dissemination
Myxopapillary ependymomas have historically been
considered benign tumors with rare cases of tumor dis-
semination; only six cases of disseminated MPE were re-
ported in the literature prior to 1996.14 Since the advent of
MR imaging, reported cases of tumor dissemination have
increased significantly. 
In 1984 Chan, et al.,1 reviewed a series of seven pedia-
tric patients younger than 13 years of age who were suf-
fering from MPEs; two experienced tumor dissemination
3.5 and 4.5 years after resection, respectively. Note that no
patient in the series underwent perioperative screening of
the CNS axis or CSF cytology screening to detect tumor
dissemination. It is unclear, therefore, whether the metas-
tases were present at the time of the initial evaluation or
whether they represent disease progression. 
In 1996 Rezai, et al.,9 reported a series of 140 adult and
pediatric patients with ependymomas of the CNS. Included
were at least eight patients with MPEs; investigations re-
vealed a 33% incidence of tumor dissemination at the 5-
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TABLE 1
Summary of reported cases of MPEs in pediatric patients*
Periop Disease Status
Authors & Age (yrs), Evaluation Tumor Dissemination Treat- at Last
Year Sex Location for Metastasis (time frame/location) Recurrence ment† Follow Up
Chan, et al., 1984 9, M CCF unknown late/cranial dissemination GTR/RT2 NAD
9, M CCF unknown late/cranial dissemination GTR/RT2 NAD
13, M CCF unknown none local GTR/reop NAD
11, M CCF unknown none none STR/RT1 NAD
8, F CCF unknown none none GTR NAD
13, M CCF unknown none none STR/RT1 NAD
10, F CCF unknown none none GTR NAD
Gagliardi, et al., 1993 14, M CCF unknown none none GTR NAD
13, F CCF unknown none local STR/reop NAD
14, M CCF unknown none none GTR NAD
13, M CCF unknown none none STR/RT1 NAD
Ross, et al., 1993 11, F not reported unknown none none GTR/RT1 NAD
12, M not reported unknown none none GTR/RT1 NAD
9, M not reported unknown none none GTR/RT1 NAD
Nagib & O’Fallon, 5, F CCF postop MR imaging none none GTR NAD
1997 8, M CCF postop MR imaging none local GTR/RT2 NAD
13, F CCF postop MR imaging none none GTR NAD
Merchant, et al., 2000 12, M CCF MRI & CSF cytology presentation/spinal none STR/chemo/RT1 DOC
8, F cervical MRI & CSF cytology presentation/spinal none STR/chemo/RT1 NAD
17, M CCF MRI & CSF cytology presentation/spinal none STR/RT1 st dis
8, F CCF MRI & CSF cytology none none STR/RT1 NAD
present series 14, M CCF preop MRI presentation/spinal none STR/RT1 NAD
14, M CCF preop MRI presentation/cranial & spinal none GTR/RT1 NAD
8, M CCF preop MRI presentation/spinal none STR/RT1 NAD
13, F CCF pre- & postop MRI spinal at presentation & late cranial none GTR/RT1/RT2 st dis
7, M CCF preop MRI (spine only) none none GTR NAD
* CCF = lesion in the conus medullaris, cauda equina, or terminal filum; chemo = chemotherapy; DOC = died of other causes; GTR = gross-total resec-
tion; NAD = no apparent disease; RT1 = radiation therapy given during the perioperative period as adjuvant therapy; RT2 = radiation therapy used to treat
late recurrence (local or disseminated disease); st dis = stable disease; STR = subtotal resection.
† The terms gross-total resection and subtotal resection apply only to the primary tumor mass; CNS metastases may still be present.
year follow up in the patients suffering from MPEs. Inter-
estingly, in the patients with MPEs the investigators re-
ported no case of dissemination evident at the time of ini-
tial presentation or during the first 3 years of the follow-up
period. Whether these patients received perioperative
screening for tumor dissemination and the means by which
the disseminated disease was detected––as an incidental
finding on follow-up MR imaging examinations or as a
clinical finding––are unclear in the paper. In the case re-
ported by Chan, et al.,1 it is unclear whether these cases of
late dissemination represent clinically latent disease that
was present but undetected at the time of initial evaluation
or instances of seeding at the time of surgery. 
In 1999 Merchant, et al.,5 reported 25 cases of spinal
cord tumors in pediatric patients. Four of these cases in-
volved MPEs, including one case of a cervical cord prima-
ry lesion. All patients underwent perioperative screening
for subarachnoid metastasis and, based on the findings of
MR imaging or CSF cytology, dissemination was noted in
three of the four cases.
In our series of five patients, the tumor dissemination
incidence of 80% at the time of the initial evaluation is
consistent with the finding of Merchant and colleagues.5
When all case series in which patients underwent periop-
erative screening for dissemination are combined, the in-
cidence of dissemination is 58%. The lower incidence of
dissemination reported in the papers published prior to
1994 probably reflects the difficulty in obtaining complete
CNS images.
Treatment of Primary and Disseminated Disease
Primary lesions in the lumbar thecal sac are almost al-
ways treated surgically, and the surgeon’s goal is generally
gross-total resection. When subtotal resection is performed,
it is usually followed by radiotherapy; this combined ap-
proach had demonstrated very good disease control. Our
results and an analysis of the literature support the use of
radiotherapy in cases of subtotal resection. Of 10 patients
who underwent subtotal resection, nine underwent postop-
erative radiotherapy and there were no tumor recurrences in
this group. One patient did not undergo radiotherapy and
was noted to have suffered disease progression. An analy-
sis of the findings in adult series also indicates that radia-
tion therapy improves outcomes in cases of subtotal resec-
tion or metastases.12 The efficacy of radiation therapy in
cases of gross-total resection is less clear. In this review, 11
patients underwent gross-total resection without adjuvant
therapy. Four subsequently suffered progressive disease;
two experienced a local recurrence and two metastatic dis-
ease. Were these patients to have been treated with radio-
therapy, the treatment would most likely have been local-
ized; therefore, it is questionable whether the disseminated
disease could have been prevented. The two local recur-
rences that developed after gross-total resection had been
performed might have been prevented by the administra-
tion of adjuvant radiotherapy; however, these lesions were
controlled very well when radiotherapy was administered
at the time of recurrence. 
Because of the effectiveness of surgery and radiation
therapy, chemotherapy has been used rarely in young chil-
dren with ependymomas or for the treatment of tumors
that are refractory to radiation therapy.4
Outcomes for Patients With MPEs
Despite the relatively high rate of tumor dissemination,
MPEs appear to be characterized by a benign course and
good long-term survival. In the patients in our series sur-
gery and radiation therapy as needed for cases of metas-
tases effectively controlled dissemination. Effective tumor
control was likewise evident in pediatric series in the litera-
ture; there are no deaths reported in the pediatric series as a
result of tumor. The mean follow-up period is only 6.4
years in this combined case series, however, and this limits
conclusions regarding long-term outcome. In all cases ei-
ther residual disease or stable disease was reported.
Other series comprising adult and pediatric patients
confirm good long-term survival rates. Mork and Loken7
reported 100% survival in nine patients with MPE who
were treated surgically; long-term follow up ranged from
5 to 22 years. Sonneland, et al.,12 described 77 cases of pa-
tients with MPEs treated at the Mayo clinic during a 60-
year period. A mortality rate of 6.5% was associated with
the MPEs; all deaths occurred after a prolonged course of
treatment and multiple recurrences. En bloc tumor remov-
al was associated with a decreased risk for tumor recur-
rence in comparison with total resection accomplished in
a piecemeal fashion (10% compared with 34%). Total re-
moval of tumor, by either en bloc or piecemeal resection,
was associated with longer survival in comparison with
subtotal resection (19 years compared with 14 years). 
Conclusions
In view of the cases reported here and in the recent liter-
ature, the incidence of CNS dissemination of MPEs ap-
pears to be higher than previously thought; this is true at
the time of diagnosis and during follow up. Screening of
the entire CNS axis at the time of diagnosis and during
follow up is therefore recommended. The limited data on
treatment for this lesion indicate that radiotherapy is effi-
cacious for residual tumor following subtotal resection
and for metastatic disease. Long-term survival has been
documented; however, continued follow up of patients
with MPEs is warranted.
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